References
- VogelRCrickRPNewsonRBShipleyMBlackmoreHBulpittCJAssociation between intraocular pressure and loss of visual field in chronic simple glaucomaBr J Ophthalmol1990741362306441
- TeusMACastejónMACalvoMAPérez-SalaícesPMarcosAIntraocular pressure as a risk factor for visual field loss in pseudoex-foliative and in primary open-angle glaucomaOphthalmology199810512222522299855151
- Terminology and guidelines for glaucomaIIIrd ed2008 European Glaucoma Society Web site. Available at: http://www.eugs.org/eng/EGS_guidelines.asp. Accessed 2010 Jul 27.
- SommerATielschJMKatzJRelationship between intraocular pressure and primary open-angle glaucoma among white and black Americans. The Baltimore Eye SurveyArch Ophthalmol19911098109010951867550
- MaoLKStewartWCShieldsMBCorrelation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucomaAm J Ophthalmol1991111151551985490
- HeijlALeskeMCBengtssonBHymanLBengtssonBHusseinMReduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
- HolmstromSBuchholzPWaltJWickstrømJAagrenMAnalytic review of bimatoprost, latanoprost and travoprost in primary open-angle glaucomaCurr Med Res Opin200521111875188316307709
- Travatan® [Package insert]Fort Worth, TXAlcon Laboratories, Inc2004
- SultanMBMansbergerSLLeePPUnderstanding the importance of IOP variables in glaucoma: A systematic reviewSurv Ophthalmol200954664366219665744
- AsraniSZeimerRWilenskyJGieserDVitaleSLindenmuthKLarge diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucomaJ Glaucoma20009213414210782622
- NetlandPALandryTSullivanEKTravoprost Study GroupTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol2001132447248411589866
- KonstasAGKozobolisVPKatsimprisIEEfficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patientsOphthalmology2007114465365717197028
- UusitaloHPillunatLERopoAPhase III Study InvestigatorsEfficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III studyActa Ophthalmol2010881121920420586
- HollóGThe side effects of the prostaglandin analoguesExpert Opin Drug Saf200761455217181451
- KonstasAGHolloGAstakhovYSFactors associated with long-term progression or stability in exfoliation glaucomaArch Ophthalmol20041221293314718291